Related Experiment Video
Updated: Jul 17, 2026
08:13
Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers
Published on: January 28, 2020
[Metastatic transitional cell carcinoma with high CA 19.9 serum levels]
Jean-Yves Camain1, Pascal Hammel, Dominique Cazals-Hatem
1Pôle des Maladies de l'Appareil Digestif, Hôpital Beaujon, Clichy.
Gastroenterologie Clinique Et Biologique
|February 3, 2007
Summary
A 75-year-old woman with urothelial carcinoma and liver metastases showed significantly elevated CA 19-9 levels. This case explores the reasons for this increase, which is also seen in biliary tract diseases.
Area of Science:
- Oncology
- Biochemistry
Background:
- Urothelial carcinoma is a significant malignancy.
- Liver metastases can complicate cancer treatment.
- CA 19-9 is a tumor marker often associated with gastrointestinal and pancreatic cancers.
Observation:
- A 75-year-old female patient presented with liver metastases from urothelial carcinoma.
- Serum levels of carbohydrate antigen 19-9 (CA 19-9) were markedly elevated in this patient.
Findings:
- The elevated CA 19-9 levels in this urothelial carcinoma case mimicked those typically seen in biliary tract diseases.
- The study discusses potential mechanisms underlying this unusual tumor marker elevation.
Implications:
- This case highlights the importance of considering non-biliary causes for elevated CA 19-9.
- Understanding these mechanisms may aid in more accurate cancer diagnosis and monitoring.
- Further research into tumor marker behavior in metastatic urothelial carcinoma is warranted.
